Centre Hospitalier Universitaire de Grenoble (CHUG)

Research site

France BP 217, 38043 Grenoble, France

Hormone receptor positive HER2 negative breast cancer
Adult patients

About Specializations

Centre Hospitalier Universitaire de Grenoble (CHUG) in Grenoble, France specialises in clinical trials of conditions such as Hormone receptor positive HER2 negative breast cancer, and other specialisations. This site conducts important research.

Hormone receptor positive HER2 negative breast cancer

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

BP 21738043 GrenobleFrance

Open in maps ↗

Recruiting now: no trials
Conditions studied: 1

More sites in Grenoble France

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Quick filters

1 clinical trial

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Study Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence

Registered drugNo placebo

Study Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Anastrozole
Sponsor:Stemline Therapeutics Inc.

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites